Investing.com - Financial Markets Worldwide

Vivos Therapeutics Inc (VVOS)

NASDAQ
Currency in USD
4.1500
-0.1200(-2.81%)
Real-time Data·
VVOS Scorecard
Full Analysis
Quickly burning through cash
VVOS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
3.54004.2500
52 wk Range
1.98007.9500
Key Statistics
Edit
Prev. Close
4.27
Open
4.1
Day's Range
3.54-4.25
52 wk Range
1.98-7.95
Volume
341.27K
Average Volume (3m)
752.49K
1-Year Change
64.23%
Book Value / Share
0.75
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VVOS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Buy
Price Target
4.2250
Upside
+1.81%
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 11
Stock price movements are quite volatile
Unlock InvestingPro

Vivos Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

Vivos Therapeutics Inc Company Profile

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

Industry
Healthcare Equipment & Supplies
Sector
Healthcare
Employees
113
Market
United States

Vivos Therapeutics Inc Earnings Call Summary for Q2/2025

  • Q2 2025 EPS of -$0.55 missed forecast by 41.03%; revenue slightly beat at $3.8M
  • Stock closed down 4.04% at $4.45; company maintains 'Fair' financial health score
  • Expanding Sleep Optimization teams from 1.5 to 4.5 by year-end; exploring acquisitions
  • Anticipates cash flow positivity by Q4 2025; operating loss of $4.9M in Q2
  • Transition to VIP enrollment model impacted revenue; SCN acquisition added $500K
Last Updated: 19/08/2025, 23:02
Read Full Transcript

Compare VVOS to Peers and Sector

Metrics to compare
VVOS
Peers
Sector
Relationship
P/E Ratio
−2.7x−0.1x−0.6x
PEG Ratio
−0.030.030.00
Price/Book
6.9x1.0x2.6x
Price / LTM Sales
2.1x0.9x3.3x
Upside (Analyst Target)
15.4%37.6%40.1%
Fair Value Upside
Unlock11.7%5.3%Unlock

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 4.2250
(+1.81% Upside)

Earnings

Latest Release
Aug 19, 2025
EPS / Forecast
-0.55 / -0.39
Revenue / Forecast
3.80M / 3.78M
EPS Revisions
a
a
Unlock
Last 90 days

VVOS Income Statement

People Also Watch

Bitmine Immersion Tech
50.12
BMNR
+0.68%
Sonnet Biotherapeutics Holdings
3.2899
SONN
+3.13%
Vor Biopharma
2.195
VOR
+7.07%
Sarepta
20.09
SRPT
-0.45%
BioNexus Gene Lab
5.2600
BGLC
-1.13%

FAQ

What Stock Exchange Does Vivos Trade On?

Vivos is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Vivos?

The stock symbol for Vivos is "VVOS."

What Is the Vivos Market Cap?

As of today, Vivos market cap is 24.50M.

What Is Vivos's Earnings Per Share (TTM)?

The Vivos EPS (TTM) is -1.70.

When Is the Next Vivos Earnings Date?

Vivos will release its next earnings report on 11 Nov 2025.

From a Technical Analysis Perspective, Is VVOS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Vivos Stock Split?

Vivos has split 1 times.

How Many Employees Does Vivos Have?

Vivos has 113 employees.

What is the current trading status of Vivos (VVOS)?

As of 20 Aug 2025, Vivos (VVOS) is trading at a price of 4.15, with a previous close of 4.27. The stock has fluctuated within a day range of 3.54 to 4.25, while its 52-week range spans from 1.98 to 7.95.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.